Fig. 10From: An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarkerIHC staining. Representative IHC images of TIMELESS expression in human cancers. a–c Clinical specimens (100× and 200×): breast cancer (a), lung cancer (b) and renal cancer (c). d–i HPA database (100 nm): breast cancer (d), colorectal cancer (e), lung cancer (f), liver cancer (g), thyroid cancer (h), and renal cancer (i)Back to article page